Guaifenesin clinical trials
Also written Mucinex®.
How each study uses Guaifenesin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Guaifenesin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 12 Jul 2002 · MUCINEX · NDA 021282 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
19 studies that test it; most in 2009 (4)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 14 · Other 6
Reckitt Benckiser LLC (6) · Reckitt Benckiser Inc. (4) · University of North Carolina, Chapel Hill (2) · American Health Research (1) · Yuzuncu Yil University (1) · Virginia Commonwealth University (1) · Massachusetts Eye and Ear Infirmary (1) · Nexgen Pharma, Inc (1)
Often tested with
Tested in the same studies.
Estradiol (1) · Hydrocodone (1) · Codeine (1) · Dexchlorpheniramine (1) · Pseudoephedrine (1)
Studies
Open first, then newest update. How each study uses Guaifenesin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 20
- Study to Evaluate the Effects of Oral Glyceryl Guiacolate (Guaifenesin, GGE) on Sputum Rheology in Subjects With Mucus HypersecretionNot yet recruitingPhase 4University of North Carolina, Chapel HillNCT07873632Written as Glycerol GuiacolateHow we know
- A Study to Explore if Long-term Use of Mucinex Can Help With Symptoms in Patients With Stable Chronic Bronchitis.CompletedPhase 4American Health ResearchNCT05843669Written as Guafenesin tabletsHow we know
- Vaginal Estradiol and Oral Guaifenesin in Clomiphene Ovulation InductionCompletedNot applicableYuzuncu Yil UniversityNCT07398924Written as GuaifenesinHow we know
- Mucinex Exploratory Cold StudyCompletedPhase 2Reckitt Benckiser Inc.NCT01046136Written as guaifenesin (Mucinex)How we know
- Safety and Efficacy Study of Guaifenesin and Pseudoephedrine for Symptomatic Therapy to Treat Acute RTICompletedPhase 4Reckitt Benckiser Inc.NCT01202279Written as GuaifenesinHow we know
- The Effect of Oral Guaifenesin on Pediatric Chronic Rhinitis: A Pilot StudyCompletedPhase 2Virginia Commonwealth UniversityNCT01364467Written as GuaifenesinHow we know
- Mucinex® for Treatment of Filamentary KeratitisCompletedNot applicableMassachusetts Eye and Ear InfirmaryNCT02859246Written as Mucinex®How we know
- Study to Evaluate Drug-drug Interactions of Guaifenesin and Hydrocodone BitartrateCompletedPhase 1Reckitt Benckiser LLCNCT03642873Written as Humibid®How we know
- Mucinex® ER 600 mg Bi-layer Tablet Versus Guaifenesin Immediate Release (IR) 200 mg q4hCompletedPhase 1Reckitt Benckiser Inc.NCT03642262Written as Mucinex®How we know
- Mucinex® ER 600 mg Bi-Layer Tablet Fed and FastedCompletedPhase 1Reckitt Benckiser LLCNCT03649750Written as Mucinex®How we know
- Study to Evaluate the Safety and Tolerability of Mucinex™(Guaifenesin) 600 mg Extended-Release Bi-Layer Tablets in the Treatment of Otherwise Healthy Patients With Symptoms of Cough, Thickened Mucus and Chest CongestionCompletedPhase 4Reckitt Benckiser LLCNCT03725085Written as Mucinex™ extended-release (SE)How we know
- Study to Evaluate the Pharmacokinetics of Mucinex 600 mg Extended-release Bi-layer Tablet in Healthy VolunteersCompletedPhase 1Reckitt Benckiser Inc.NCT03644108Written as Mucinex® ER 600 mgHow we know
- Study to Evaluate the Pharmacokinetics of Mucinex® 1200 mg Extended-Release TabletCompletedPhase 1Reckitt Benckiser LLCNCT03633487Written as Mucinex®How we know
- Evaluating the Effect of Mucinex 1200mg on Mucociliary and Cough Clearance During an Acute Respiratory InfectionCompletedPhase 2Reckitt Benckiser LLCNCT01114581Written as MucinexHow we know
- Codeine Phosphate/Guaifenesin ER Tablet 30 mg/600 mg Steady State Clinical StudyCompletedPhase 1Nexgen Pharma, IncNCT02572375Written as Codeine Phosphate/Guaifenesin ER TabletHow we know
- Exploratory Efficacy Study of Guaifenesin in Upper Back PainCompletedNot applicableGlaxoSmithKlineNCT01562548Written as GuaifenesinHow we know
- Safety and Efficacy of Mucinex and IR Guaifenesin the Treatment of Symptoms of Acute Upper Respiratory Tract InfectionsCompletedPhase 2/3Reckitt Benckiser LLCNCT01537081Written as MucinexHow we know
- Study of Count Coughs in Subjects With Acute Upper Respiratory Tract InfectionsCompletedNot applicableWyeth is now a wholly owned subsidiary of PfizerNCT01062256Written as GuaifenesinHow we know
- Evaluating the Effect of Mucinex® 1200 mg on Mucociliary and Cough Clearance From the Human LungCompletedPhase 1University of North Carolina, Chapel HillNCT00902707Written as Mucinex 1200mgHow we know
- Comparison Between Dexchlorpheniramine and Dexchlorpheniramine/Pseudoephedrine/Guaifenesin in Respiratory InfectionsStatus unknownPhase 3Mantecorp Industria Quimica e Farmaceutica Ltd.NCT01085721Written as Dexchlorpheniramine, pseudoephedrine, guaifenesinHow we know
Given beside what is tested · 1 — Guaifenesin is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with Guaifenesin
Codes
What other systems call Guaifenesin · ClinicalTrials.gg INT007587
- MeSH (NLM) D006140GuaifenesinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 495W7451VQGUAIFENESINConfirmed FDA, NLM, Wikidata
- RxNorm 5032Confirmed FDA, Wikidata
- Wikidata Q420682guaifenesinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C29081GuaifenesinOne source FDA
- DrugBank DB00874One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D006140 | Guaifenesin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 495W7451VQ | GUAIFENESIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 5032 | — | Confirmed FDA, Wikidata |
| Wikidata | Q420682 | guaifenesin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C29081 | Guaifenesin | One source FDA |
| DrugBank | DB00874 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.